Podcasts about Health law

Perimenopause brings a lot of changes but there is good news! You see, when you understand what's actually happening in your body, you can take back control.   In this week's episode of The Perimenopause Solution, I sit down with Jill Chmielewski, RN, BSN to unpack the critical metabolic and biological shifts that happen during perimenopause, and what you can do right now to support your body, energy, and long-term health.   In the episode, we cover: The surprising connection between your hormones, muscle, and metabolism How to spot the early signs of imbalance before they spiral out of control  When HRT makes sense vs. when it might not What you can start doing today to support your energy, mood, and longevity   Midlife isn't a downhill slide but an invitation to approach your health in a whole new way. You have options, and this episode will help you understand them.   Jill Chmielewski, RN, BSN Jill Chmielewski, RN, BSN, is a Registered Nurse, Health Coach, Menopause Educator, and Women's Health Advocate with over 30 years of experience in healthcare. She is a bold voice in the midlife health movement, calling out the outdated belief that it's all downhill after 40—and replacing it with something far more powerful: the truth that a woman's next chapter can be her strongest, healthiest, and most vibrant yet. Jill holds a Master of Jurisprudence in Health Law and is a certified health coach from the Institute for Integrative Nutrition (IIN). She has completed advanced training through the School of Applied Functional Medicine and the Institute of Bioidentical Medicine, with deep expertise in menopause, hormones, and hormone replacement therapy (HRT). As Education Lead at Respin Health, founded by Halle Berry, Jill combines science-based education with deep compassion and clinical insight, helping women understand their bodies, advocate for their health, and make informed, confident decisions. Her work is rooted in the belief that decline is not inevitable—it's simply what happens when we fail to adapt to our bodies' needs in midlife and as we age. Jill is the co-creator of two personalized Menopause Health & Hormone Optimization programs, the creator of The Beginner's Guide to Hormone Replacement Therapy, and a trusted clinician known for making complex topics clear, approachable, and actionable. Most recently, Jill was featured in the groundbreaking menopause docuseries "Four Days," created by filmmaker Charles Mattocks and a passionate team of experts and women willing to share their stories. The series was born from a quiet question: What if we finally changed the conversation, and turned into a movement? Because the silence around menopause has gone on too long. And because women deserve to be seen, heard, and supported in this next chapter of life. The docuseries is expected to air in late fall 2025.  Jill's Links:  Website Instagram Respin Health HRT Telehealth Programs for women in the following states: California, Washington, Idaho, Montana, Arizona, Illinois, and Ohio   Watch on Youtube HERE.   Mentioned in this episode: HRT Made Simple™ - Learn how to confidently speak to your doctor about the benefits of hormone replacement therapy so you can set yourself up for symptom-free, unmedicated years to come without feeling confused, dismissed, or leaving the medical office minus your HRT script. Hair Loss Solutions Made Simple™ – This course will teach you the best natural, highly effective, and safe solutions for your hair loss so you can stop it, reverse it, and regrow healthy hair without turning to medications. The Perimenopause Solution™ – My signature 6-month comprehensive hormonal health program for women in midlife who want to get solid answers to their hormonal health issues once and for all so they can kick the weight gain, moodiness, gut problems, skin issues, period problems, fatigue, overwhelm, insomnia, hair/eyebrow loss, and other symptoms in order to get back to the woman they once were. [FREE] The Ultimate Midlife Perimenopause Handbook - Grab my free guide and RECLAIM your confidence, your mood, your waistline and energy without turning to medications or restrictive diets (or spending a fortune on testing you don't need!).   [BOOK A 30-MINUTE SESSION WITH TARA HERE]  

The Food and Drug Administration or FDA regulates roughly 78% of the US food supply. This includes packaged products, food additives, infant formula, ultra-processed foods, and lots more. However, an analysis by the Environmental Working Group found that 99% of new food ingredients enter our food supply through a legal loophole that skirts FDA oversight and seems, to me at least, to be incredibly risky. Today we're speaking with two authors of a recent legal and policy analysis published in the Journal Health Affairs. They explain what this loophole is and its risks and suggest a new user fee program to both strengthen the FDA's ability to regulate food ingredients and address growing concerns about food safety. Our guests are Jennifer Pomeranz Associate Professor of Public Health Policy and Management at New York University School of Global Public Health and Emily Broad, director of Harvard Law School Center for Health Law and Policy Innovation. Interview Summary So Jennifer, let's start with you, help our listeners understand the current situation with food ingredient oversight. And what is this legal loophole that allows food companies to add new ingredients without safety reviews. Sure. So, Congress passed the Food Additives Amendment in 1958, and the idea was to divide food additives and generally recognized as safe ingredients into two different categories. That's where the GRAS term comes from generally recognized as safe? ‘Generally Recognized As Safe' is GRAS. But it circularly defines food additives as something that's not GRAS. So, there's not actually a definition of these two different types of substances. But the idea was that the food industry would be required to submit a pre-market, that means before it puts the ingredient into the marketplace, a pre-market petition to the FDA to review the safety. And then the FDA promulgates a regulation for safe use of a food additive. GRAS ingredients on the other hand, initially thought of as salt, pepper, vinegar, are things like that would just be allowed to enter the food supply without that pre-market petition. The problem is the food industry is the entity that decides which category to place each ingredient. There's no FDA guidance on which category they're supposed to ascribe to these ingredients. What has happened is that the food industry has now entered into the food supply an enormous amount of ingredients under what we call the GRAS loophole, which is allowing it to just bring it to the market without any FDA oversight or even knowledge of the ingredient. So, in essence, what we're having now is that the food industry polices itself on whether to submit this pre-market petition for a food additive or just include it in its products without any FDA knowledge. When you said ‘enormous number of such things,' are we talking dozens, hundreds, thousands? Nobody knows, but the environmental working group did find that 99% of new ingredients are added through this loophole. And that's the concerning part. Well, you can look at some ultra-processed foods and they can have 30 or 40 ingredients on them. That's just one food. You can imagine that at across the food supply, how many things there are. And there are these chemicals that nobody can pronounce. You don't know what's going on, what they are, what they're all about. So, what you're saying is that the food industry decides to put these things in foods. There's some processing reason for putting them in. It's important that the public be protected against harmful ingredients. But the food industry decides what's okay to put in and what's not. Are they required to do any testing? Are there criteria for that kind of testing? Is there any sense that letting the industry police itself amounts to anything that protects the public good? Well, the criteria are supposed to be the same for GRAS or food additives. They're supposed to be meeting certain scientific criteria. But the problem with this is that for GRAS ingredients, they don't have to use published data and they can hold that scientific data to themselves. And you mentioned food labels, the ingredient list, right? That doesn't necessarily capture these ingredients. They use generic terms, corn oil, color additive, food additive whatever. And so, the actual ingredient itself is not necessarily listed on the ingredient list. There is no way to identify them and it's unknown whether they're actually doing the studies. They can engage in these, what are called GRAS panels, which are supposed to be experts that evaluate the science. But the problem is other studies have found that 100% of the people on these GRAS panels have financial conflicts of interest. Okay, so let me see if I have this right. I'm a food company. I develop a new additive to provide color or flavor or fragrance, or it's an emulsifier or something like that. I develop a chemical concoction that hasn't really been tested for human safety. I declare it safe. And the criteria I use for declaring it set safe is putting together a panel of people that I pay, who then in a hundred percent of cases say things are. That's how it works? I can't say that in a hundred percent of cases they say it's safe, but a hundred percent of the people have financial conflicts of interest. That's one of the major concerns there. Well, one can't imagine they would continue to be paid... Exactly. This sounds like a pretty shaky system to be sure. Emily: I wanted to add a couple other really quick things on the last discussion. You were saying, Kelly, like they're using a panel of experts, which indeed are paid by them. That would be best case in some cases. They're just having their own staff say, we think this is generally recognized as safe. And I think there's some examples we can give where there isn't even evidence that they went to even any outside people, even within industry. I think that the takeaway from all of that is that there's really the ability for companies to call all the shots. Make all the rules. Not tell FDA what they're doing. And then as we talked about, not even have anything on the label because it's not a required ingredient if it's, used as part of a processing agent that's not a substance on there. So I was feeling pretty bad when Jennifer is talking about these panels and the heavy conflict... Even worse. Of interest, now I feel worse because that's the best case. Totally. And one other thing too is just you kind of warmed this up by talking about this loophole. When we put an earlier article out that we wrote that was about just this generally recognized as safe, the feedback we got from FDA was this isn't a loophole. Why are you calling this a loophole? And it's pretty clear that it's a loophole, you know? It's big enough to drive thousands of ingredients through. Yes, totally. Emily, you've written about things like partially hydrogenated vegetable oils, trans fats, and red dye number three in particular. Both of which FDA has now prohibited in food. Can you walk us through those cases? You asked about partially hydrogenated oils or trans-fat, and then red dye three, which are two examples that we talk about a little bit in our piece. Actually, one of those, the partially hydrogenated oils was allowed in food through the generally recognized as safe definition. And the other was not. But they are both really good examples of another real issue that FDA has, which is that not only are they not doing a good job of policing substances going into food on the front end, but they do an even worse job of getting things out of food on the backend, post-market once they know that those substances are really raising red flags. And you raised two of the prime examples we've been talking about. With partially hydrogenated oils these are now banned in foods, but it took an extremely long time. Like the first evidence of harm was in the mid-nineties. By 2005, the Institute of Medicine, which is now the National Academies, said that intake of trans fat, of partially hydrogenated oils, should be as low as possible. And there was data from right around that time that found that 72,000 to 228,000 heart attacks in the US each year were caused by these partially hydrogenated oils. And on FDA's end, they started in early 2000s to require labeling. But it wasn't until 2015 that they passed a final rule saying that these substances were not generally recognized as safe. And then they kept delaying implementation until 2023. It was basically more than 20 years from when there was really clear evidence of harm including from respected national agencies to when FDA actually fully removed them from food. And red dye number three is another good example where there were studies from the 1980s that raised concerns about this red dye. And it was banned from cosmetics in 1990. But they still allowed it to be added to food. And didn't ban it from food until early this year. So early 2025. In large part because one of the other things happening is states are now taking action on some of these substances where they feel like we really need to protect consumers in our states. And FDA has been doing a really poor job. California banned red dye about 18 months before that and really spurred FDA to action. So that 20-year delay with between 72,000 and 228,000 heart attack deaths attributable to the trans fats is the cost of delay and inaction and I don't know, conflicts of interest, and all kinds of other stuff that happened in FDA. So we're not talking about something trivial by any means. These are life and death things are occurring. Yes. Give us another example, if you would, about something that entered the food supply and caused harm but made it through that GRAS loophole. The example that I've talked about both in some of the work we've done together and also in a perspective piece in the New England Journal of Medicine that really focused on why this is an issue. There was this substance added to food called tara flour. It came on the scene in 2022. It was in food prepared by Daily Harvest as like a protein alternative. And they were using it from a manufacturer in South America who said we have deemed this generally recognized as safe. Everything about that is completely legal. They deemed it generally recognized as safe. A company put it into food, and they sold that. Up until that point, that's all legal. What happened was very quickly people started getting really sick from this. And so there were, I think, about 400 people across 39 states got sick. Nearly 200 people ended up in the hospital, some of them with liver failure because of this toxicity of tara flour. And so FDA followed the thread they did help work with the company to do a voluntary recall, but it then took them two years, until May, 2024, to declare tara flour not generally recognized as safe. So I think, in some ways, this is a great example because it shows how it's so immediate, the impact of this substance that, again, was legally added to food with no oversight. In some ways it's a misleading example because I think so many of the substances in food, it's not going to be so clear and so immediate. It's going to be year over year, decade over decade as part of a full diet that these are causing cardiovascular risk, thyroid disease, cancer risk, those kinds of things. I'd love to hear from either of you about this. Why is FDA falling down on the job so badly? Is it that they don't have the money to do the necessary testing? Do they not have the authority? Is there not the political will to do this? Is there complete caving into the food industry? Just let them do what they want and we're going let it go? Jennifer: All of the above? Everything you just said? It's all of the above. Emily: Jen, do you wanna talk about the money side? Because that sort of gets to the genesis of the article we worked on, which was like maybe there's a creative solution to that piece. Yes, I'd love to hear about that because I thought that was a very creative thing that you guys wrote about in your paper. That there would be an industry user fee to help produce this oversight. Tell us what you had in mind with that. And then then convince me that FDA would appropriately use this oversight and do its job. So, the idea in the paper was proposing a comprehensive user fee program for the food branch of the FDA. The FDA currently collects user fees for all of human drugs, animal drugs, medical devices, etc. With Tobacco, it's a hundred percent funded by user fees. But food, it only gets 1% of its funding through user fees. And it's important to note user fees fund processes. They don't fund outcomes. It's not like a bribe. And the idea behind user fees and why industry sometimes supports them is actually to bring predictability to the regulatory state. It brings efficiency to reviews. And then this all allows the industry to anticipate timelines so they can bring products to market and know when they're going be able to do it. In the food context, for example, the FDA is required to respond to those food additives petitions that we talked about within 180 days. But they can't respond in time. And they have a lot of timelines that are required of them in the food context that they can't meet. They can't meet their timelines because they're so underfunded. So, we proposed a comprehensive user fee. But one of the main reasons that we think a user fee is important is to address the pre-market issues that I talked about and the post-market issues that Emily talked about. In order to close that GRAS loophole, first of all, FDA needs to either reevaluate its authorities or Congress needs to change its authorities. But it would need resources to be able to do something pre-market. Some of the ideas we had was that the user fee would fund some type of either pre-market review, pre-market notification, or even just a pre-market system where the FDA determines whether a proposed ingredient should go through the GRAS avenue, or through food additive petition. So at least that there will be some type of pre-market oversight over all the ingredients in the food supply. And then also the FDA is so severely lacking in any type of comprehensive post-market into play, they would have the resources to engage in a more comprehensive post-market review for all the ingredients. Could you see a time, and I bring this up because of lawsuits against the food industry for some of these additives that are going on now. The state attorney's generals are starting to get involved, and as you said, Emily, the some states are taking legislative action to ban certain things in the food supply. Do you think there could come a time when the industry will come to government pleading to have a user fee like this? To provide some standardization across jurisdictions, let's say? So, there's two things. The first is Congress has to pass the user fee, and historically, actually, industry has done exactly what you said. They have gone to Congress and said, you know what? We want user fees because we want a streamlined system, and we want to be able to know when we're bringing products to market. The problem in the context of food for the issues we're talking about is that right now they can use the GRAS loophole. So, they have very little incentive to ask for user fees if they can bring all their ingredients into the market through the GRAS loophole. There are other areas where a user fee is very relevant, such as the infant formula 90 day pre-market notification, or for different claims like health claims. They might want user fees to speed those things up, but in terms of the ingredients, unless we close the GRAS loophole, they'd have little incentive to actually come to the table. But wouldn't legal liability change that? Let's say that some of these lawsuits are successful and they start having to pay large settlements or have the State Attorneys General, for example, come down on them for these kinds of things. If they're legally liable for harm, they're causing, they need cover. And wouldn't this be worth the user fee to provide them cover for what they put in the food supply? Yes, it's great to have the flexibility to have all these things get through the loophole, but it'd be great as well to have some cover so you wouldn't have so much legal exposure. But you guys are the lawyers, so I'm not sure it makes sense. I think you're right that there are forces combining out in the world that are pushing for change here. And I think it's hard to disentangle how much is it that industry's pushing for user fees versus right now I think more willing to consider federal regulatory changes by either FDA or by Congress. At the state level this is huge. There's now becoming a patchwork across states, and I think that is really difficult for industry. We were tracking this year 93 bills in 35 states that either banned an additive in the general public, banned it in schools. Banned ultra-processed foods, which most of the states, interestingly, have all defined differently. But where they have had a definition, it's been tied to various different combinations of additives. So that's going on. And then I think you're right, that the legal cases moving along will push industry to really want clear and better standards. I think there's a good question right now around like how successful will some of these efforts be? But  what we are seeing is real movement, both in FDA and in Congress, in taking action on this. So interestingly, the Health Affairs piece that we worked on was out this spring. But we had this other piece that came out last fall and felt like we were screaming into the void about this is a problem generally recognized as safe as a really big issue. And suddenly that has really changed. And so, you know, in March FDA said they were directed by RFK (Robert F. Kennedy), by HHS (Health and Human Services) to really look into changing their rule on generally recognized as safe. So, I know that's underway. And then in Congress, multiple bills have been introduced. And I know there are several in the works that would address additives and specifically, generally recognized as safe. There's this one piece going on, which is there's forces coalescing around some better method of regulation. I think the question's really going to also be like, will Congress give adequate resources? Because there is also another scenario that I'm worried about that even if FDA said we're going now require at least notification for every substance that's generally recognized as safe. It's a flood of substances. And they just, without more resources, without more staff devoted to this, there's no way that they're going to be able to wade through that. So, I think that either the resources need to come from user fees, or at least partially from user fees, from more appropriations and I think, In my opinion, they are able to do that on their own. Even given where current administrative law stands. Because I think it's very clear that the gist of the statute is that FDA should be overseeing additives. And I think a court would say this is allowing everything to instead go through this alternative pathway. But I really think FDA's going to need resources to manage this. And perhaps more of a push from Congress to make sure that they really do it to the best of their ability. I was going to say there's also an alternative world where we don't end up spending any of these resources, and they require the industry just to disclose all the ingredients they've added to food and put it on a database. This is like low hanging fruit, not very expensive, doesn't require funding. And then the NGOs, I hope, would go to work and say, look at this. There is no safety data for these ingredients. You know, because right now we just can't rely on FDA to do anything unless they get more funding to do something. So, if FDA doesn't get funding, then maybe this database where houses every ingredient that's in the food supply as a requirement could be a low resource solution. Jennifer, I'll come back to you in a minute because I'd like to ask how worried should we be about all this stuff that's going into food. But Emily, let me ask you first, does FDA have the authority to do what it needs to do? Let's say all of a sudden that your wish was granted and there were user fees would it then be able to do what needs to be done? I think certainly to be able to charge these user fees in almost all areas, it right now doesn't have that authority, and Congress would need to act. There's one small area which is within the Food Safety Modernization Act for certain types of like repeat inspections or recalls or there's a couple other. FDA isn't charging fees right now because they haven't taken this one step that they need to take. But they do have the authority if they just take those steps. But for everything else, Congress has to act. I think the real question to me is because we now know so many of these substances are going through this GRAS pathway, the question is really can they do everything they need to do on their own to close that loophole? And again, my opinion is Congress could make it clear and if Congress were to act, it would be better. Like they could redefine it in a way that was much more clear that we are drawing a real line. And most things actually should be on the additive side of the line rather than the generally recognized as safe side of the line. But even with their current authority, with the current definition, I think FDA could at least require notification because they're still drawing a line between what's required for additives, which is a very lengthy pre-market process with, you know, a notice and comment procedure and all of these things. My take is FDA do what you can do now. Let's get the show on the road. Let's take steps here to close up the loophole. And then Congress takes time. But they definitely can even strengthen this and give a little more, I think, directives to FDA as to how to make sure that this loophole doesn't recur down the line. In talks that I've given recently, I've shown an ingredient list from a food that people will recognize. And I ask people to try to guess what that food is from its ingredient list. This particular food has 35 ingredients. You know, a bunch of them that are very hard to pronounce. Very few people would even have any idea at all what those ingredients do. There's no sense at all about how ingredient number 17 would interact with ingredient 31, etc. And it just seems like it's complete chaos. And I don't want to take you guys outside your comfort zone because your backgrounds are law. But Jennifer, let me ask you this. You have a background in public health as well. There are all kinds of reasons to be worried about this, aren't there? There are the concerns about the safety of these things, but then there's a concern about what these ultra-processed ingredients do to your metabolism, your ability to control your weight, to regulate your hunger and things like that. It sounds this is a really important thing. And it's affecting almost everybody in the country. The percentage of calories that are now coming from ultra-processed foods is over 50% in both children and adults. So it sounds like there's really reason to worry. Would you agree? Yes. And also, the FDA is supposed to be overseeing the cumulative effects of the ingredients and it doesn't actually enforce that regulation. Its own regulation that it's supposed to evaluate the cumulative effects. It doesn't actually enforce this. So by cumulative effects do you mean the chronic effects of long term use? And, having these ingredients across multiple products within one person's consumption. Also, the FDA doesn't look at things like the effect on the gut microbiome, neurotoxicity, even cancer risk, even though they're supposed to, they say that if something is GRAS, they don't need to look at it because cancer risk is relegated only to food additives. So here we're at a real issue, right? Because if everything's entering through the GRAS loophole, then they're not looking at carcinogen effects. So, I think there is a big risk and as Emily had said earlier, that these are sometimes long-term risks versus that acute example of tara flour that we don't know. And we do know from the science, both older and emerging science, that ultra-processed food has definite impact on not only consumption, increased consumption, but also on diet related diseases and other health effects. And by definition what we're talking about here are ultra-processed foods. These ingredients are only found in ultra-processed foods. So, we do know that there is cause for concern. It's interesting that you mentioned the microbiome because we've recorded a cluster of podcasts on the microbiome and another cluster of podcasts on artificial sweeteners. Those two universes overlap a good bit because the impact of the artificial sweeteners on some of them, at least on the microbiome, is really pretty negative. And that's just one thing that goes into these foods. It really is pretty important. By the way, that food with 35 ingredients that I mentioned is a strawberry poptart. Jennifer: I know that answer! Emily: How do you know that? Jennifer: Because I've seen Kelly give a million talks. Yes, she has. Emily: I was wondering, I was like, are we never going to find out? So the suspense is lifted. Let me end with this. This has been highly instructive, and I really appreciate you both weighing in on this. So let me ask each of you, is there reason to be optimistic that things could improve. Emily, I'll start with you. So, I've been giving this talk the past few months that's called basically like Chronic Disease, Food Additives and MAHA, like What Could Go Right and What Could Go Wrong. And so, I'm going give you a very lawyerly answer, which is, I feel optimistic because there's attention on the issue. I think states are taking action and there's more attention to this across the political spectrum, which both means things are happening and means that the narrative changing, like people are getting more aware and calling for change in a way that we weren't seeing. On the flip side, I think there's a lot that could go wrong. You know, I think some of the state bills are great and some of them are maybe not so great. And then I think this administration, you have an HHS and FDA saying, they're going to take action on this in the midst of an administration that's otherwise very deregulatory. In particular, they're not supposed to put out new regulations if they can get rid of 10 existing ones. There are some things you can do through guidance and signaling, but I don't think you can really fix these issues without like real durable legislative change. So, I'm sorry to be one of the lawyers here. I think the signals are going in the right direction, but jury is out a little bit on how well we'll actually do. And I hope we can do well given the momentum. What do you think, Jennifer? I agree that the national attention is very promising to these issues. The states are passing laws that are shocking to me. That Texas passing a warning label law, I would never have thought in the history of the world, that Texas would be the one to pass a warning label law. They're doing great things and I actually have hope that something can come of this. But I am concerned at the federal level of the focus on deregulation may make it impossible. User fees is an example of where they won't have to regulate, but they could provide funding to the FDA to actually act in areas that it has the authority to act. That is one solution that could actually work under this administration if they were amenable to it. But I also think in some ways the states could save us. I worry, you know, Emily brought up the patchwork, which is the key term the industry uses to try to get preemption. I do worry about federal preemption of state actions. But the states right now are the ones saving us. California is the first to save the whole nation. The food industry isn't going to create new food supply for California and then the rest of the country. And then it's the same with other states. So, the states might be the ones that actually can make some real meaningful changes and get some of the most unsafe ingredients out of the food supply, which some of the states have now successfully done. Bios Emily Broad Leib is a Clinical Professor of Law, Director of Harvard Law School Center for Health Law and Policy Innovation, and Founding Director of the Harvard Law School Food Law and Policy Clinic, the nation's first law school clinic devoted to providing legal and policy solutions to the health, economic, and environmental challenges facing our food system. Working directly with clients and communities, Broad Leib champions community-led food system change, reduction in food waste, food access and food is medicine interventions, and equity and sustainability in food production. Her scholarly work has been published in the California Law Review, Wisconsin Law Review, Harvard Law & Policy Review, Food & Drug Law Journal, and Journal of Food Law & Policy, among others. Professor Jennifer Pomeranz is a public health lawyer who researches policy and legal options to address the food environment, obesity, products that cause public harm, and social injustice that lead to health disparities. Prior to joining the NYU faculty, Professor Pomeranz was an Assistant Professor at the School of Public Health at Temple University and in the Center for Obesity Research and Education at Temple. She was previously the Director of Legal Initiatives at the Rudd Center for Food Policy and Obesity at Yale University. She has also authored numerous peer-reviewed and law review journal articles and a book, Food Law for Public Health, published by Oxford University Press in 2016. Professor Pomeranz leads the Public Health Policy Research Lab and regularly teaches Public Health Law and Food Policy for Public Health.

In this mini-series, we explore different health professions to get a better understanding of the variety of team members involved in patient care. For this episode, we chatted with Andre Moore about his journey in healthcare law.Andre Moore is a Chicago native and a final-semester law student at Loyola University Chicago School of Law, where he is a fellow at the Beazley Institute for Health Law and Policy. He earned his undergraduate degree from the University of Illinois at Chicago's (UIC) School of Public Health. Over the past two summers, he gained in-house legal experience, most recently at the American Dental Association, where he worked on healthcare compliance and data privacy and security matters.Episode produced by: Deborah ChenEpisode recording date: 4/29/2025www.medicuspodcast.com | medicuspodcast@gmail.com | Donate: http://bit.ly/MedicusDonateContact info for Andre Moore: lmoore22@luc.edu

Sheela Ranganathan, Adjunct Professor, Georgetown University School of Health, speaks with Kim Mutcherson, Professor, Rutgers Law School, and Diana Kasdan, Legal and Policy Director, UCLA Law Center on Reproductive Health, Law, and Policy, about the current landscape of reproductive health law. They discuss the Supreme Court's recent decision in Medina v. Planned Parenthood South Atlantic, the ongoing battles over mifepristone in the courts, the rapidly evolving patchwork of state-level shield laws that are designed to protect patient privacy, how the withdrawal of Biden-era EMTALA guidance is reshaping emergency abortion care, and what to expect going forward.Watch this episode: https://www.youtube.com/watch?v=494HcIzfXVAFor more news and analysis on this topic, visit AHLA's Reproductive Health Law Hub: https://www.americanhealthlaw.org/publications/health-law-hub-current-topics/reproductive-law Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

In this episode of Repast, Michael and Diana host Emily Broad Leib, Clinical Professor of Law, Director of Harvard Law School Center for Health Law and Policy Innovation, and Founding Director of the Harvard Law School Food Law and Policy Clinic (FLPC), and Akif Khan, Clinical Fellow at the FLPC. They discuss the FLPC's long history of working on food waste and food date labeling, and a comment the FLPC recently submitted in response to the U.S. Department of Agriculture (USDA), Food Safety and Inspection Service (FSIS), and the U.S. Food and Drug Administration (FDA) Request for Information on Food Date Labeling, drafted by Akif. Michael T. Roberts is the Executive Director of the Resnick Center for Food Law and Policy at UCLA Law.Diana Winters is the Deputy Director of the Resnick Center for Food Law & Policy at UCLA Law. The link to the FLPC's comment is here.The link to the Zero Food Waste Coalition comment is here.You can find the FLPC's Food Loss and Waste Policy Hub here.

In this Ortho Marketing episode, Dean Steinman is joined by Gary Sastow, Partner at Danziger & Markhoff LLP, to discuss the legal essentials every dental practice owner needs to know. From regulatory compliance and risk management to contracts and employee matters, Gary shares expert insights to help practices stay protected and legally sound. Whether you're starting, growing, or managing a practice, this episode is packed with must-know legal guidance.Ready to elevate your practice?Contact us! https://orthomarketing.com/contact-us/About Gary SastowGary Sastow has over twenty-five years of experience in the practice of law. While maintaining a broad scope of practice, Gary focuses on representing healthcare professionals in all aspects of their business, professional and personal lives. Having been raised in a family of physicians, he possesses a unique understanding and insight into the business of practicing a healthcare profession. Combined with his years of practice in what has become a more complex and highly regulated industry, Gary's clients see him as a trusted advisor, confidant, and advocate. On an ongoing basis, he works with clients on transactional matters, regulatory compliance issues and problem solving including providing representation to clients under professional investigation before OPMC, OPD or the Justice Center. Gary is a prolific speaker and author of professional articles in various publications. He has also served as an adjunct professor at Pace University teaching Health Law and Policy and Not for Profit Organizations. Gary is a recommended legal services provider for the NYS Dental Association. D&M now provides representation to clients under professional investigation before OPMC, OPD or the Justice Center

In this Ortho Marketing episode, Dean Steinman is joined by Gary Sastow, Partner at Danziger & Markhoff LLP, to discuss the legal essentials every dental practice owner needs to know. From regulatory compliance and risk management to contracts and employee matters, Gary shares expert insights to help practices stay protected and legally sound. Whether you're starting, growing, or managing a practice, this episode is packed with must-know legal guidance.Ready to elevate your practice?Contact us! https://orthomarketing.com/contact-us/About Gary SastowGary Sastow has over twenty-five years of experience in the practice of law. While maintaining a broad scope of practice, Gary focuses on representing healthcare professionals in all aspects of their business, professional and personal lives. Having been raised in a family of physicians, he possesses a unique understanding and insight into the business of practicing a healthcare profession. Combined with his years of practice in what has become a more complex and highly regulated industry, Gary's clients see him as a trusted advisor, confidant, and advocate. On an ongoing basis, he works with clients on transactional matters, regulatory compliance issues and problem solving including providing representation to clients under professional investigation before OPMC, OPD or the Justice Center. Gary is a prolific speaker and author of professional articles in various publications. He has also served as an adjunct professor at Pace University teaching Health Law and Policy and Not for Profit Organizations. Gary is a recommended legal services provider for the NYS Dental Association. D&M now provides representation to clients under professional investigation before OPMC, OPD or the Justice Center

In this episode of Voices in Health Law, host Jeff Wurzburg (Norton Rose Fulbright) welcomes NSA expert and Bracewell partner Carrie Douglas for a candid conversation on the real-world implementation of the No Surprises Act. Douglas shares valuable insights on maximizing reimbursement, navigating arbitration, and the ongoing enforcement challenges impacting providers. She also highlights what's working, what still needs fixing, and how legislation could better support the Act's original intent—keeping patients out of payment disputes.

Food Tank, in partnership with the Food is Medicine Institute at Tufts University, recently hosted a luncheon on Capitol Hill to uplift Food is Medicine solutions. This episode of Food Talk with Dani Nierenberg features conversations from the event where speakers discussed the public health and economic benefits of Food is Medicine programs, the opportunities to scale their impact, and the partnerships that can accelerate these efforts. Speakers include U.S. Members of Congress Vern Buchanan, Buddy Carter, Robin Kelly, Greg Murphy, and Chellie Pingree; Laura Carroll, U.S. Food and Drug Administration; Dion Dawson, Dion's Chicago Dream; Kofi Essel, Elevance Health; Erika Hanson, Center for Health Law and Policy Innovation of Harvard Law School; Herman Johnson, U.S. Army Veteran and Food is Medicine program participant; Erin Martin, FreshRx Oklahoma; Crystal McGaffee, ARH Hospital and Food is Medicine program participant; Dariush Mozaffarian, Food is Medicine Institute; Evan Sarris, Kroger Health; Pam Schwartz, Kaiser Permanente; and Dana Thomas, The Rockefeller Foundation. While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to “Food Talk with Dani Nierenberg” wherever you consume  your podcasts.

In the final installment of our three-part series on healthcare privacy, Voices in Health Law host Ramana Rameswaran is joined by Adam Greene of Davis Wright Tremaine and Jaysen Park of VMG Health for an in-depth discussion on the Biden administration's proposed updates to the HIPAA Security Rule. The conversation explores the motivations behind the overhaul, including growing cybersecurity threats and enforcement challenges, and examines the implications for covered entities and business associates—particularly smaller healthcare practices. The episode also highlights practical steps regulated entities can take now to prepare, despite the uncertain regulatory future.

Chimpanzees use medicinal plants for first aid and hygieneResearchers have observed wild chimpanzees seeking out particular plants, including ones known to have medicinal value, and using them to treat wounds on themselves and others. They also used plants to clean themselves after sex and defecation. Elodie Freymann from Oxford University lived with the chimpanzees in Uganda over eight months and published this research in the journal Frontiers in Ecology and Evolution.Why this evolutionary dead end makes understanding extinction even more difficult540 million years ago, there was an explosion of animal diversity called the Cambrian explosion, when nature experimented with, and winnowed many animal forms into just a few. A new discovery of one of the unlucky ones that didn't make it has deepened the mystery of why some went extinct, because despite its strangeness, it shows adaptations common to many of the survivors. Joseph Moysiuk, curator of paleontology and geology at the Manitoba Museum helped identify the fossil, and published on it in Royal Society Open Science A quantum computer demonstrates its worth by solving an impossible puzzleImagine taking a sudoku puzzle, handing bits of it to several people, putting them in separate rooms, and asking them to solve the puzzle. A quantum computer using the weird phenomenon of “entanglement” was able to do something analogous to this, which serves as evidence that it really is exploiting quantum strangeness, and could be used for more practical purposes. David Stephen, a physicist at the quantum computing company Quantinuum, and colleagues from the University of Boulder published on this finding in Physical Review Letters.Roadkill shows that most mammals have fluorescent furA researcher who used a range of mammal and marsupial animals killed by vehicles, has demonstrated that the fur of many of these animals exhibit biofluorescence – the ability to absorb light and re-emit it in different wavelengths. They were able to identify some of the fluorescent chemicals, but don't know why these animals would glow like this. Zoologist Linda Reinhold observed bright colours such as yellow, blue, green and pink on Australian animals like the bandicoot, wallaby, tree-kangaroo, possums and quolls. Their research was published in the journal PLOS One.Science suggests humans are not built for the information ageWe are living in the age of information. In fact, we're drowning in it. Modern technology has put vast amounts of information at our fingertips, and it turns out that science is showing that humans just aren't that good at processing all that data, making us vulnerable to bias, misinformation and manipulation.Producer Amanda Buckiewicz spoke to:Friedrich Götz, an Assistant Professor of Psychology at the University of British Columbia.Vasileia Karasavva, a PhD student in the Department of Psychology at the University of British Columbia.Timothy Caulfield, professor in the Faculty of Law and the School of Public Health at the University of Alberta, and was the Canada Research Chair in Health Law and Policy from 2002 - 2023.Eugina Leung, an assistant professor of marketing at the A.B. Freeman School of Business at Tulane University.Jonathan Kimmelman, a medical ethicist based at McGill University.

This is a free preview of a paid episode. To hear more, visit rethinkingwellness.substack.comHealth-misinformation researcher and science communicator Timothy Caulfield returns to discuss his new book THE CERTAINTY ILLUSION, why being too certain about anything makes us vulnerable to misinformation, how intellectual humility can help protect us, why science is sometimes “full of shit” and how to be a critical consumer of it, and more. Behind the paywall, we get into why it's so hard for public figures to show intellectual humility, whether being smart makes people less intellectually humble and more vulnerable to misinformation, the role of narcissism in misinformation belief, the Dunning-Kruger effect, and why so many researchers lie about their work. Plus, Christy asks Tim for advice on how to navigate an alternative-medicine recommendation for IVF, and whether refusing to do it is a hill she wants to die on.Paid subscribers can hear the full interview, and the first half is available to all listeners. To upgrade to paid, go to rethinkingwellness.substack.com.Timothy Caulfield is a Professor in the Faculty of Law and the School of Public Health, and Research Director of the Health Law Institute at the University of Alberta. He was the Canada Research Chair in Health Law and Policy for over 20 years (2002 - 2023). His interdisciplinary research on topics like stem cells, genetics, research ethics, the public representations of science, and public health policy has allowed him to publish almost 400 academic articles. He has won numerous academic, science communication, and writing awards, and is a Member of the Order Canada and a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, and the Committee for Skeptical Inquiry. He contributes frequently to the popular press and is the author of national bestsellers: The Cure for Everything: Untangling the Twisted Messages about Health, Fitness and Happiness (Penguin 2012) and Is Gwyneth Paltrow Wrong About Everything?: When Celebrity Culture and Science Clash (Penguin 2015), and Relax, Dammit!: A User's Guide to the Age of Anxiety (Penguin Random House, 2020).  His most recent book is The Certainty Illusion: What You Don't Know and Why It Matters (Penguin Random House, 2025; Bookshop affiliate link). Caulfield is also the co-founder of the science engagement initiative #ScienceUpFirst and has written, hosted and produced documentaries, including the award-winning TV show, A User's Guide to Cheating Death, which has been shown in over 60 countries, including streaming on Netflix in North America.If you like this conversation, subscribe to hear lots more like it! Support the podcast by becoming a paid subscriber, and unlock great perks like extended interviews, subscriber-only Q&As, full access to our archives, commenting privileges and subscriber threads where you can connect with other listeners, and more. Learn more and sign up at rethinkingwellness.substack.com.Christy's second book, The Wellness Trap, is available wherever books are sold! Order it here, or ask for it in your favorite local bookstore.If you're looking to make peace with food and break free from diet and wellness culture, come check out Christy's Intuitive Eating Fundamentals online course.

Food Tank, in partnership with the Sprouts Healthy Communities Foundation, recently hosted a special series on “Food is Medicine and Eating for Health.” This webinar features conversations  from Part 2 of the event as panelists come together to discuss avenues to scale Food is Medicine programs at the state level, the importance of ensuring communities have access to culturally relevant foods, and why the best Food is Medicine programs serve eaters, farmers, and the planet. Speakers include Katie Garfield, Harvard Law School's Center for Health Law and Policy Innovation; Devon Klatell, The Rockefeller Foundation; Radha Muthiah, Capital Area Food Bank; Tambra Raye Stevenson, Women Advancing Nutrition Dietetics and Agriculture (WANDA); Chef Sean Sherman, North American Traditional Indigenous Food Systems (NATIFS); and Lyndsey Waugh of the Sprouts Healthy Communities Foundation.  While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to “Food Talk with Dani Nierenberg” wherever you consume your podcasts.

Important changes are unfolding in the vaccine space. How have vaccine exemptions posed a significant risk to populations across the country? What are the long-lasting effects of the new administration's federal health agency funding cuts? On this episode, Epstein Becker Green attorneys Richard Hughes, Spreeha Choudhury, and Will Walters, as well as Anna Larson of EBG Advisors, discuss vaccine-related topics ranging from the measles outbreak and the reduction of the federal workforce to decreased government funding of public health programs.  If you are interested in getting access to Epstein Becker Green's publicly available shared information, please use the following link to subscribe: https://www.ebglaw.com/subscribe. Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc88. Visit: http://diagnosinghealthcare.com. This podcast is presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

Sandy DiVarco, Partner, McDermott Will & Emery LLP, and Dan Hettich, Partner, King & Spalding LLP, discuss issues related to Medicare and the practice of law in this area. They cover Medicare reimbursement for hospitals, different licensure requirements, EMTALA, provider-based status and site-neutral care, the Advocate Christ case, and what it's like as an attorney to practice in a niche area like Medicare law. Sandy and Dan, among others, were authors of AHLA's Fundamentals of Health Law, Eighth Edition.Watch the conversation here.AHLA's Health Law Daily Podcast Is Here! AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this new podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

During the first wave of the opioid pandemic, the U.S. federal government encouraged states to establish prescription drug monitoring programs (PDMPs) which use predictive algorithms to determine risk scores for patients. These scores, which can point correctly or inaccurately to substance use disorder (SUD), drug diversion, doctor shopping or drug misuse, have a risk themselves, as overreliance on PDMP information for clinical decision making often influences clinicians in their treatment, or refusal to treat, vulnerable people. In this episode, we speak with health law and policy expert Elizabeth Pendo, UW Law's senior associate dean for academic affairs and Kellye Y. Testy Professor of Law. Pendo, who co-wrote the recently published paper, “Challenging Disability Discrimination in the Clinical Case of PDMP Algorithms” in the Carolina Law Review, challenges PDMP algorithmic discrimination, which is far from regulated, as disability discrimination through the lens of federal antidiscrimination laws. Pendo also talks about the revitalization of UW Law's Health Law program through the upcoming launch of the Health Law & Policy Program.  

This week, we're sharing a special clip from a recent episode of a podcast we love, rePROs Fight Back, where Madeline Morcelle, Senior Attorney at the National Health Law Program, breaks down why Medicaid is essential to sexual and reproductive healthcare—and what's at stake with proposed funding cuts. Medicaid currently insures over 72 million people, covering critical reproductive health services like family planning, pregnancy-related care, and abortion (within Hyde Amendment exceptions). But with massive budget cuts on the table, millions of low-income individuals—especially Black, Indigenous, and other people of color, people with disabilities, LGBTQ+ individuals, and young people—could see their access to care drastically reduced. Listen to the full episode Listen to rePROs Fight Back CONNECT WITH US Instagram: @sexedwithdbpodcast TikTok: @sexedwithdbTwitter: @sexedwithdb Threads: @sexedwithdbpodcast YouTube: Sex Ed with DB ROM-COM VOM SEASON 11 SPONSORS: Lion's Den, Uberlube, Magic Wand, & Arya. Get discounts on all of DB's favorite things here! GET IN TOUCH Email: sexedwithdb@gmail.comSubscribe to our newsletter for behind-the-scenes content and answers to your sexual health questions! FOR SEXUAL HEALTH PROFESSIONALS Check out DB's workshop: "Building A Profitable Online Sexual Health Brand" ABOUT THE SHOW Sex Ed with DB is your go-to podcast for smart, science-backed sex education—delivering trusted insights from top experts on sex, sexuality, and pleasure. Empowering, inclusive, and grounded in real science, it's the sex ed you've always wanted. SEASON 11 TEAM Creator, Host & Executive Producer: Danielle Bezalel (DB) Producer: Sadie Lidji Communications Lead: Cathren Cohen Logo Design: Evie Plumb (@cliterallythebest)  

Hayden Rooke-Ley is a Health Law and Policy Fellow at the Brown University School of Public Health and a Senior Fellow at the American Economic Liberties Project. In this episode of Second Request, Hayden discusses vertical consolidation in health care markets, UnitedHealth Group's outsized lead in this trend with Medicare Advantage, and the capitated payment model undergirding this shift.

It is critical for health care and life sciences businesses to understand what might and might not change during this transitionary period. How can you advocate for your needs and priorities in a time of such uncertainty?  On this episode, Epstein Becker Green (EBG) attorneys James Boiani, Rachel Snyder Good, Marjorie Scher, and Rob Wanerman discuss the proposed leadership of the U.S. Department of Health and Human Services under the second Trump administration and the top-ticket items for these potential new leaders. Chevron deference article mentioned in today's show This podcast was recorded on January 23, 2025. Since then, EBG has put out several important free resources in response to President Trump's executive orders and other executive actions to make sure EBG subscribers have the information they need to navigate any uncertainty. Some examples include: DEI and Affirmative Action Programs Blitzed, While Executive Order 11246 Is Revoked Navigating Executive Orders: Insights and What Lies Ahead The Trump Administration's Immigration Enforcement Policy: What Hospitals and Health Care Providers Must Know for Their Patients, Staff, and Visitors Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc85. Subscribe for email notifications: https://www.ebglaw.com/subscribe. Visit: http://diagnosinghealthcare.com. This podcast is presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

NEWS: Hontiveros: Bill boosts reproductive health law | Jan 28, 2025Visit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

Carmel Shachar is an assistant clinical professor of law and faculty director of the Health Law and Policy Clinic at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Ramesh, C. Shachar, and H. Yu. Striking a Balance — Advancing Physician Collective-Bargaining Rights and Patient Protections. N Engl J Med 2025;392:209-211.

Part 1:We talk with Paul Shafer, Assistant Professor, Health Law and Policy, Boston University.We discuss the health insurance industry, and how it prevents subscribers from actually getting the health care that they need. We look at the main methods by which they do this, and how they skirt the ACA to prevent paying out to insured people.Part 2:We talk with Julie Ingersoll, Professor of Religious Studies at the University of North Florida.We discuss the nomination of Hegseth to be Secretary of Defense.We examine the qualifications that that have been cited. But we also look at his background, and the new apologies offered for his scandals, and his 'rebirth' as a fundamental christian. He is part of a 'christian reconstruction' cult which, in his mind, and, according to his new church overrides any US laws. We discuss his relationship with David Bartlett, a far right christian evangelist. WNHNFM.ORG  productionMusic: David Rovics, "Time to Act", for Will Von Sproson

Judith Waltz, Partner, Foley & Lardner LLP, Dionne Lomax, Managing Director of Antitrust and Trade Regulation, Affiliated Monitors, Inc., and Dee Anna Hays, Shareholder, Ogletree Deakins, discuss some of the key health law developments in 2024 and what to expect in 2025. They cover a wide range of legislative, regulatory, and judicial issues but mainly focus on Medicare and Medicaid, antitrust, and labor and employment. Waltz, Lomax, and Hays are editors of AHLA's bestselling title, Federal Health Care Laws and Regulations, which contains a brand-new 2024 supplement.Watch the conversation here.AHLA's Health Law Daily Podcast Is Here! AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this new podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

There are many ways to assess the quality of care that pregnant people receive pre- and post-partum, as well as during delivery itself. Dr. Kathryn Thompson shares her findings on how the care that pregnant Black Medicaid enrollees receive compares to their more affluent white peers, and the policy and practice opportunities for addressing the social determinants of health that are involved.  Kathryn Thompson is an Assistant Professor at Boston University's School of Public Health in the departments of Community Health Sciences and Health Law, Policy, and Management. She is also an IRP 2024–2025 Visiting Poverty Scholar. 

My guest today is Aziza Ahmed, a Professor of Law and N. Neal Pike Scholar at the Boston University School of Law. She is also a Co-Director of BU Law's Program on Reproductive Justice. She joins me and UVA Law 3L, Nia Saunders, to discuss her new book Risk and Resistance: How Feminists Transformed the Law and Science of AIDS, forthcoming from Cambridge University Press in 2025. Prior to teaching, Professor Ahmed was a research associate at the Harvard School of Public Health Program on International Health and Human Rights. She came to that position after a Women's Law and Public Policy Fellowship where she worked with the International Community of Women Living with HIV/AIDS. Professor Ahmed was a member of the Technical Advisory Group on HIV and the Law convened by the United Nations Development Programme (UNDP) and has been an expert for many institutions, including the American Bar Association and UNDP.Reading ListAhmed BioLinda C. McClain & Aziza Ahmed, The Routledge Companion to Gender and Covid-19 (2024)SCHOLARLY COMMONSNicole Huberfeld, Linda C. McClain & Aziza Ahmed,Rethinking Foundations and Analyzing New Conflicts: Teaching Law after Dobbs 17 Saint Louis University Journal of Health Law & Policy (2024). SCHOLARLY COMMONSAziza Ahmed, Dabney P. Evans, Jason Jackson, Benjamin Mason Meier & Cecília Tomori, Dobbs v. Jackson Women's Health: Undermining Public Health, Facilitating Reproductive Coercion 51 Journal of Law, Medicine & Ethics (2023)SCHOLARLY COMMONSAziza Ahmed, Feminist Legal Theory and Praxis after Dobbs: Science, Politics, and Expertise 34 Yale Journal of Law and Feminism (2023)SCHOLARLY COMMONSKrawiec Bio

(00:00) Introduction (02:27) Petrie-Flom Center Open House – Health Law, Biotechnology, and the Future (51:55) Q&A --- Support this podcast: https://podcasters.spotify.com/pod/show/theunadulteratedintellect/support

With so many conspiracy theories, misinformation and disinformation being shared both intentionally and unintentionally, how are Albertans supposed to navigate the minefield that our information ecosystem has become?In this episode we sit down with renowned expert in navigating that minefield, Timothy Caulfield to try and figure exactly that out!From his Univeristy of Alberta bio..."Timothy Caulfield is a Professor in the Faculty of Law and the School of Public Health, and Research Director of the Health Law Institute at the University of Alberta. He was the Canada Research Chair in Health Law and Policy for over 20 years (2002 - 2023). His interdisciplinary research on topics like stem cells, genetics, research ethics, the public representations of science, and public health policy has allowed him to publish almost 400 academic articles. He has won numerous academic, science communication, and writing awards, and is a Member of the Order Canada and a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, and the Committee for Skeptical Inquiry."You can donate to skipping stone at https://www.skippingstone.ca/legalfundDon't forget, we have merch that's available at https://www.abpoli.ca/category/the-breakdown-ab!As always, if you appreciate the kind of content that we're trying to produce here at The Breakdown, please consider signing up as a monthly supporter at our Patreon site at www.patreon.com/ thebreakdownab and we can now accept e-transfers at info@thebreakdownab.ca!If you're listening to the audio version of our podcast, please consider leaving us a review and a rating, and don't forget to like and follow us on Blue Sky, Facebook, Twitter, Instagram and Threads!

Twenty-six states have passed bans on gender-affirming care for transgender minors, and the Supreme Court is set to hear arguments in December about Tennessee's ban. We take a closer look at gender-affirming care and the legal arguments that could influence how accessible that care is.Meredithe McNamara, MD, Assistant Professor of Pediatrics, Yale School of MedicineKatie Eyer, JD, Professor of Law, Rutgers Law SchoolJames Blumstein, LLB, University Distinguished Professor of Constitutional Law and Health Law & Policy, Vanderbilt University Law SchoolLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Alé Dalton, Partner, Bradley Arant Boult Cummings LLP, speaks with Ari Markenson, Partner, Venable LLP, about how early career professionals can use the complexities of the health care industry to their advantage. They discuss why the average health care lawyer is like a “Swiss Army Knife,” how to navigate the sea of acronyms that exist in the health care industry, what the heavily regulated nature of health care means for the practice of law, the value of attending AHLA's Fundamentals of Health Law conference, and the importance of lifelong learning and establishing one's professional brand. Ari is Editor-in-Chief of the brand-new title, AHLA's Health Care Law and Policy Acronyms and Terms. From AHLA's Early Career Professionals Council.Watch the conversation here.To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Mark Wicclair is an adjunct professor of medicine at the University of Pittsburgh Center for Bioethics and Health Law and a professor of philosophy emeritus at West Virginia University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.B. White and M. Wicclair. Navigating Clinicians' Conscience-Based Refusals to Provide Lawful Medical Care. N Engl J Med 2024;391:1465-1467.

In this episode, we break down California's newly signed Latino and Indigenous Disparities Reduction Act, a groundbreaking law addressing healthcare disparities for Indigenous Latin Americans. From better data collection to improving care for Indigenous communities, we explore how this law will reshape the state's healthcare system and why it's a major win for equity. Tune in for a quick dive into what this law means and the impact it will have on California's diverse population.   BONUS EPISODES Patreon: ✨www.patreon.com/latinamericaneo✨

***Warning: This episode talks about sensitive topics***November 5, 2024 is a crucial election in the United States for many reasons. The country is polarized. Even many states are polarized.Colorado's Amendment 79 would enshrine abortion as a fundamental right into the state constitution. It would even allow the legislature to pass laws that pay for it on demand with taxes.Colorado is the premier destination for abortion in the country. The state has no restrictions on abortion.Could Amendment 79 and future laws based on it encourage people from outside the state to flock in and make residents pay to end the life of their unborn children. Could the language of the amendment set up barriers to stopping human trafficking?Pray for Colorado. Speak the truth.Sources Cited:Colorado 2024 Amendment 79 on BallotopediaJesse Paul, "Amendment 79: An attempt to preserve abortion access in Colorado's constitution," Colorado Sun, Updated October 11, 2024.Frances Rossi and Tom Perille, "Opinion: Initiative 89 would prevent Colorado from ever regulating third-trimester abortions," Denver Post, Updated July 23, 2024.Laura J. Lederer and Christopher A. Wetzel, "The Health Consequences of Sex Trafficking and Their Implications for Identifying Victims in Healthcare Facilities," Annals of Health Law 23, no. 1 (Winter 2014): 61-91.Arduizur Carli Richie-Zavaleta, et al, "Sex Trafficking Victims at Their Junction with the Healthcare Setting-A Mixed-Methods Inquiry," Journal of human trafficking 6, no. 1 (2020): 1-29.*** Please contribute to the Hurricane relief fund for A.M. Brewster ***We value your feedback!Have questions for Truthspresso? Contact us!

***Warning: This episode talks about sensitive topics***November 5, 2024 is a crucial election in the United States for many reasons. The country is polarized. Even many states are polarized.Colorado's Amendment 79 would enshrine abortion as a fundamental right into the state constitution. It would even allow the legislature to pass laws that pay for it on demand with taxes.Colorado is the premier destination for abortion in the country. The state has no restrictions on abortion.Could Amendment 79 and future laws based on it encourage people from outside the state to flock in and make residents pay to end the life of their unborn children. Could the language of the amendment set up barriers to stopping human trafficking?Pray for Colorado. Speak the truth.Sources Cited:Colorado 2024 Amendment 79 on BallotopediaJesse Paul, "Amendment 79: An attempt to preserve abortion access in Colorado's constitution," Colorado Sun, Updated October 11, 2024.Frances Rossi and Tom Perille, "Opinion: Initiative 89 would prevent Colorado from ever regulating third-trimester abortions," Denver Post, Updated July 23, 2024.Laura J. Lederer and Christopher A. Wetzel, "The Health Consequences of Sex Trafficking and Their Implications for Identifying Victims in Healthcare Facilities," Annals of Health Law 23, no. 1 (Winter 2014): 61-91.Arduizur Carli Richie-Zavaleta, et al, "Sex Trafficking Victims at Their Junction with the Healthcare Setting-A Mixed-Methods Inquiry," Journal of human trafficking 6, no. 1 (2020): 1-29.*** Please contribute to the Hurricane relief fund for A.M. Brewster ***We value your feedback!Have questions for Truthspresso? Contact us!

Choosing where to live can be a big decision and can even impact your life expectancy. Michael Wolfson, former assistant chief statistician at Statistics Canada and current member of the University of Ottawa's Centre for Health Law, Policy and Ethics,  discusses why. Michael Wolfson is a former assistant chief statistician at Statistics Canada and current […]

The Mississippi Center for Justice is about advancing racial and economic justice. We could take a week to talk about everything they do there, but we've only got President and CEO Vangela Wade for the next hour to learn about their work and upcoming events.The Mississippi Center for Justice opened its doors in 2003 with a simple mission: dismantling the policies that keep Mississippi at the bottom of nearly every indicator of human well-being. If you'd like to help with that – consider registering to vote. You can print off a voter registration application from the Secretary of State's website or maybe ask your county's circuit clerk's office to mail you an application.The MS Center for Justice - They're some busy folks! There's a Health Law – lunch and learn in Indianola next week in addition to a Fair Housing and Expungement Education event in Gulfport. The 3rd week of October holds a Small Farmer's Conference, a Social Justice Empowerment Brunch, the Champions of Justice Signature Event. and the Great Mississippi Road Trip scheduled. We haven't even made it out of the month. There are more events on their calendar with many more months of events taking place.Their website has ways to donate, their social media links, events, and ways to “join their fight”. https://mscenterforjustice.org/Look for the Legacy Leadership podcast of MPB Think Radio's Money TalksPast podcasts with MS Center for Justice staff:05/07/24 Robert McDuff MCJ10/17/23 Champions of Justice - MCJ 08/01/23 Expungements 03/14/23 Loans05/24/22 MCJ Heirs' Property01/25/22 Educational Rights11/09/21 Heirs' Property Help01/12/21 Asylum and Immigration Hosted on Acast. See acast.com/privacy for more information.

Tara Sklar, Faculty Director, Health Law & Policy Program, University of Arizona James E. Rogers College of Law, and Kathryn Huber, MD, Kaiser Permanente, discuss the prevalence of cognitive impairments as the U.S. population ages and the implications this has for the future of digital health care. They cover the legal and regulatory landscape and issues related to privacy, informed consent, coordination of care, and reimbursement. Tara and Kathryn recently wrote an article for AHLA's Journal of Health and Life Sciences Law on this topic.To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Erin Fuse Brown is a professor of health services, policy, and practice at the Brown University School of Public Health and a member of the Journal's Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.E. Sachs and E.C. Fuse Brown. Supreme Power — The Loss of Judicial Deference to Health Agencies. N Engl J Med 2024;391:777-779. S.H. Engels and Others. The Supreme Court's Shadowy Treatment of Public Health. N Engl J Med. DOI: 10.1056/NEJMp2408380.

Alé Dalton, Partner, Bradley Arant Boult Cummings LLP, speaks with Mara Smith-Kouba, Counsel, Bristol Myers Squibb, and Avery Schumacher, Associate, Epstein Becker & Green PC, about the experiences and challenges of Millennial and Gen Z health law professionals. They discuss the takeaways from a survey of early career professionals by Major, Lindsey & Africa, harnessing and supporting the power of mentorship, recognizing changing priorities and values around work culture and hybrid work environments, and sustaining a diverse and inclusive workforce. They also discuss the work of AHLA's Early Career Professionals Council and how to become more involved. Alé is the current Chair of AHLA's Early Career Professionals Council, and Mara and Avery are past Chairs. From AHLA's Early Career Professionals Council.To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

John Fangman, MD discusses opportunities for Medicaid program to cover health-related social needs, such as housing, nutrition and transportation with Katie Garfield, JD, Director of the Center for Health Law and Policy Innovation of Harvard Law School's Whole Person Care initiative and Michelle Collins-Ogle, MD, Director Montefiore Adolescent & Youth Sexual-health Clinic and Associate Professor of Pediatrics at Albert Einstein College of Medicine.See the companion Reimagining Medicaid, How Medicaid Can Help Address Social Determinants of Health Fact Sheet.General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19! https://idweek.org/registration/

In this episode, we will learn from Karen Jacobs, OT, EdD, OTR, CPE, FAOTA & Alyson D. Stover, MOT, JD, OTR/L, BCP about Occupational Therapy & Artificial Intelligence.Dr. Karen Jacobs is a distinguished occupational therapist with a career spanning over four decades. She is the Associate Dean of Digital Learning and Innovation, the Program Director of the post-professional doctorate in occupational therapy program, and a Clinical Professor of occupational therapy at Boston University's Sargent College of Health and Rehabilitation Sciences. She has worked at Boston University for 41 years. She holds a Doctor of Education (EdD) degree from the University of Massachusetts, a Master's degree in Occupational Therapy from Boston University and a Bachelor's degree from Washington University. She has expertise in various areas, including ergonomics, artificial intelligence, marketing, entrepreneurship, and advocacy. Her passion for enhancing occupational performance has led to extensive research, publications, and presentations worldwide. She is the founding editor-in-chief of the journal WORK: A Journal of Prevention, Assessment & Rehabilitation since 1990. Dr. Jacobs has played a pivotal role in advancing backpack safety through AOTA's National Backpack Awareness Day and promoting the recognition of occupational therapy through the creation of Occupational Therapy Global Day of Service. Both are held on World Occupational Therapy Day on October 27. As a Fellow of the American Occupational Therapy Association (FAOTA), the Human Factors and Ergonomics Society (HFES) and the International Ergonomics Association (IEA), Dr. Jacobs has been recognized for her outstanding contributions as a scholar, professor, advocate, and mentor, who has inspired countless students and practitioners. Throughout her career, Dr. Jacobs has held leadership positions such as the president and vice president of the American Occupational Therapy Association contributing to the growth and development of occupational therapy at both national and international levels. Some of her awards include the 2005 recipient of a Fulbright Scholarship in Iceland, the 2011 AOTA Eleanor Clarke Slagle Lectureship Award, the 2020 AOTA Outstanding Mentor Award and the 2024 AOTA/AOTF Presidents' Commendation in Honor of Wilma L. West.Dr. Alyson Stover is an owner and Occupational Therapist at Capable Kids. She completed her undergraduate degree in Rehabilitation Science and her Master of Occupational Therapy at the University of Pittsburgh. In 2008 she returned to school and completed her Juris Doctorate, with a Post-Graduate Certificate in Health Law, from the University of Pittsburgh School of Law. Alyson has practiced in various settings, including schools, early intervention, outpatient pediatrics and acute care and long-term rehabilitation care at Children's Hospital of Pittsburgh and the Children's Home of Pittsburgh and Lemieux Family Center. She is an associate professor at the University of Pittsburgh's Doctor of Occupational Therapy and affiliated health law faculty for the Center for Bioethics and Health Law University of Pittsburgh. Alyson serves as the President of occupational therapy's national board, AOTA. Alyson's expertise includes the holistic approach to pediatric and family evaluation and intervention, trauma-informed occupational therapy and occupation-based approaches to substance use disorder. She is trained and certified in Therapeutic Listening, Interactive Metronome, and Mental Health First Aid, as well as splinting and taping protocols. Along with working with children, Alyson provides non-lawyer advocacy for children and families who need assistance accessing resources. As a published author, nationally grant-funded research investigator, and subject-matter expert, Alyson provides continuing education for healthcare practitioners, educators, first responders, and the community. Contact & Resources:Karen Jacobs:Email: kjacobs@bu.eduLinkedIn: https://www.linkedin.com/in/karenjacobsot/Here is the link to the BU Sargent College podcast, HealthMatters: https://podcasts.apple.com/us/podcast/healthmatters/id1495983952Alyson D. Stover:Email: adstover@pitt.eduLinkedIn: https://www.linkedin.com/in/alyson-stover-8a446159/Capable Kids: https://capablekidsrehab.com/teamKorro AI:Enhance your pediatric occupational therapy practice by joining the Korro professional community (ot.korro.ai). Korro innovates occupational therapy through immersive, play-based experiences, combining engagement with efficacy. Our platform leverages personalized data analytics to drive improved outcomes. To learn more about Korro's capabilities, we invite you to:View Korro's informational video: https://vimeo.com/930246779?share=copySchedule a complimentary demonstration: https://outlook.office365.com/book/KorroDemo@korro.ai/As always, I welcome any feedback & ideas from all of you or if you are interested in being a guest on future episodes, please do not hesitate to contact Patricia Motus at transitionsot@gmail.com or DM via Instagram @transitionsotTHANK YOU for LISTENING, FOLLOWING, DOWNLOADING, RATING, REVIEWING & SHARING “The Uncommon OT Series” Podcast with all your OTP friends and colleagues!Full Episodes and Q & A only available at:https://www.wholistic-transitions.com/the-uncommon-ot-seriesSign Up NOW for the Transitions OT Email List to Receive the FREE Updated List of Uncommon OT Practice Settingshttps://www.wholistic-transitions.com/transitionsotFor Non-Traditional OT Practice Mentorship w/ Patricia:https://docs.google.com/forms/d/e/1FAIpQLSeC3vI5OnK3mLrCXACEex-5ReO8uUVPo1EUXIi8FKO-FCfoEg/viewformBIG THANKS to our sponsors Picmonic & TruelearnUSE DISCOUNT CODE “TransitionsOT” to Score 20% OFF Your Membership Today!Happy Listening Friends!Big OT Love!All views are mine and guests own.

Knock, knock! If the Drug Enforcement Administration (DEA) is already at your door, it may be too late. Enforcement is on the rise, and the microscope is fixed on controlled substances. What can industry stakeholders do to prevent penalties and protect themselves from DEA scrutiny? On this episode, Epstein Becker Green attorneys Melissa Jampol, David Johnston, and Avery Schumacher discuss recent and pending updates to DEA rules and guidance, outline steps stakeholders can take to prepare for an inspection, and share tips on what to do when the DEA arrives. Visit our site for more information and related resources: https://www.ebglaw.com/dhc80 Subscribe for email notifications: https://www.ebglaw.com/subscribe. Visit: http://diagnosinghealthcare.com. This podcast is presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

For more than six years and nearly 80 episodes, Norm Tabler has entertained AHLA with his unique take on recent health law and other legal developments. Now, Norm bids farewell to the Lighter Side of Health Law.To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

AHLA's monthly podcast featuring health lawyer and blogger Norm Tabler's informative and entertaining take on recent health law and other legal developments.To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

William “Bill” Drilling is a 1979 graduate of North High School in Sioux City, Iowa and a 1985 graduate of the University of Iowa College of Pharmacy.  Following graduation, Bill joined his father and brother as a staff pharmacist at Drilling Morningside Pharmacy.  Bill and his brother, Don purchased Drilling Pharmacy from their parents, Don and Virginia Drilling in January, 1986.  Bill's daughter, Sarah Sorensen joined the pharmacy staff in 2018 as a third-generation pharmacist at Drilling Pharmacy. Bill's highlights: • President and Pharmacist in Charge at Drilling Pharmacy 1996-current • Member of the Iowa Pharmacists Association Board of Trustees 1996-1998. • Siouxland Star Award from the Siouxland Chamber of Commerce for the store façade changes -2010 • Parade Marshall at the Morningside Days Parade – 2013 and 2022 • Featured in the Siouxland Design for the restoration of the façade and unique design of the Drilling Pharmacy façade -2013 • IPPE Preceptor Excellence Award from the University of Iowa College of Pharmacy -2019 • Member of the Iowa Pharmacy Association Platinum Level • Member of CPESN • Preceptor for University of Iowa College of Pharmacy, Drake, Creighton University and South Dakota State University • Serves as a resource for local media on pharmacy related issues • Served on the University of Iowa College of Pharmacy Building Committee • Served as an IPA Delegate, IPA Champion Advocate, IPA Legislative Committee, IPA Public Affairs Committee • Collaborated with IPA, University of Iowa, and Iowa Department of Public Health on the 1815 Project. • Reached 1,000,000 prescriptions in 2000 • Reached 2,000,000 prescriptions in 2013 • Reached 3,000,000 prescriptions in 2020 • During the COVID pandemic, Drilling Pharmacy responded to the Siouxland community by giving over 20,000 vaccinations as well as over 1,000 flu shots at both on site and in store clinics. Bill is an extremely strong believer in innovation and always looking for the next opportunity. Services we currently offer include Lipid panels, A1C test, Blood Glucose Screening, Blood Pressure Screenings, Test to Treat (COVID-19, Influenza, and Group A Strep), a wide variety of immunizations, Script Talk, Medication Synchronization, and MTM Services. OTC hearing aids are on the way! Bill enjoys getting the opportunity to work with the Iowa Department of Public Health, Iowa Pharmacy Association and the University of Iowa College of Pharmacy with various projects and grants. Ashton Maaraba has over 24 years of healthcare industry experience, he is credited with transforming several start-up healthcare brands into consumer staples. Ashton's leadership expertise stems from a prominent career in healthcare, with specialties in Health IT, Enterprise Solutions that drive value-based care and healthy patient outcomes and Direct-to-Consumer brands. Ashton was responsible for the inception-to- commercialization and the deployment of various products and services and Digital Health services across an impressive 50,000+ pharmacies, retail stores, managed care, local and national businesses, and eCommerce in the U.S, Canada, Australia, and Great Britain. He is recognized as a current expert in the architecture, commercialization, operations and revenue growth for diverse telehealth and digital healthcare assets, solutions, and products into multiple business, medical, retail and patient verticals. Ashton holds a J.D with a specialty in Health Law, has an MSc. From Nova Southeastern University and earned his BSc. from Michigan State University. He is a long-standing supporter and proponent of IPC Membership group, NCPA, APHA, NACDS, HIMMS and MEDICA and other leading organizations. Ashton started his career in pharmacy services by working with FLAVORx, a pediatric compliance-driven medication flavoring staple. He trained inside a leading independent pharmacy, Center Pharmacy, at the hands of Harold Kramm a leading independent pharmacy owner and advocate. He has been recognized for his relentless energy in pharmacy advocacy on Capitol Hill through the Rx Impact leadership group, Independent Pharmacy Cooperative and is a leading member of NY State pharmacy lobby.   Ashton has transitioned each company and product that he served to become national powerhouses. And is often credited for accelerating his company's mission and impressive growth trajectory through many of the most complex industry verticals.  Ashton has been a member of many corporate advisory boards and councils, notably, Rx Sense and InfinityRx. He has served on both the National Association of Chain Drug Stores Advisory Committee and Canada's leading community pharmacy conference committee. Ashton's top corporate highlights underscore his business acumen and passion for transcending business objectives into game-changing outcomes. At Bonum Health, he led the development, commercialization, compliance, and nationwide adoption for a national telehealth brand. He was credited with leading eRx Network (now Change Healthcare – digital healthcare network company) product and account management division. PharmaSmart (Medical Device and Data Company) & FLAVORx (Medicinal Flavoring Company). As the President and CEO at AshHEALTH, LLC. a Healthcare and Digital Health IT Market Advisory Company, Ashton advised and consulted many start-up companies operating in healthcare with a mission to advance medication adherence programs across pharmacy and physician collaboratives. Presently, Ashton is the President of IPC Digital Health, an Independent Pharmacy Cooperative company. As the head of the company's digital and virtual healthcare strategy, and Pharmacy team, Ashton is leading the development and commercialization of iCare+ a unique digital health ecosystem of virtual products and services designed to future-ready independent pharmacies.

Josh Mozell joins Mike to discuss Gov. Hobbs' veto of Senate Bill 1570. 

Joining us on Well Said is Dr. Maria Carney, Chief of the Division of Geriatric and Palliative Medicine in the Department of Medicine for Long Island Jewish Medical Center and North Shore University Hospital and Adam Kahn, Adjunct Professor with the Master's in Health Law and Policy Program at University and a Senior Fellow for the Gitenstein Institute for Health Law and Policy at Hofstra University. They will be helping us unpack the complex topic of Advanced Directives; or written statements of a person’s wishes regarding medical treatment, often including a living will, made to ensure those wishes are carried out should the person be unable to communicate them to a doctor.

In late April, the Biden administration issued new rules designed to keep prosecutors from obtaining medical records of patients who seek legal abortions. The expansion of HIPAA prohibits the disclosure of health information to state officials as part of a criminal investigation. Carmel Shachar, head of the Health Law and Policy Clinic at Harvard University, joins John Yang to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

In late April, the Biden administration issued new rules designed to keep prosecutors from obtaining medical records of patients who seek legal abortions. The expansion of HIPAA prohibits the disclosure of health information to state officials as part of a criminal investigation. Carmel Shachar, head of the Health Law and Policy Clinic at Harvard University, joins John Yang to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Changing up small habits in your day can create big changes in your life (this is the power of conscious neuroplasticity) & that's the first thing that Amy gets into with her guest (who is also her cousin) Amanda Reiger Green. Then the second thing they get into is wild...Amanda explains 'Address Numerology' (a way to change the energy of your home through numbers. i.e. Amanda tells Amy what number to use to sell her house since she's about to put it on the market, and then what number to use to make her new house feel more organized!) Speaking of organization...the third thing is about cleaning out closets (and making space in your mind) because Amanda was finally able to go through her mom's clothes (she passed away over a year ago) and donate them to the right person. Fourth thing is CONNECTION (and the importance of it) so if you're in Austin...check out Amanda's Live 'Soul Sessions' Podcast Event (May 7th) for an evening of empowerment, connection, inspiration, and healing! Amanda will be doing live psychic readings, answering Q&A, and helping people gain clarity on their purpose and meaning.    The Jim Kwik Brain Gym Video Amy Has Been Doing    Amanda's Blog on Address Numerology    HOST: Amy Brown // RadioAmy.com // @RadioAmy GUEST: Amanda Reiger Green // SoulPathology.com // @SoulPathology   Amanda  is a world-renowned psychic medium, spiritual intuitive and wellness leader. Over the past decade, she has consulted for thousands of clients including Fortune 500 companies, CEOs, world leaders, government officials, communities, institutions, and seekers from all walks of life looking for spiritual connection and a path forward in their personal evolution. Amanda empowers her clients, engaging their innate abilities to create tangible, meaningful results in their daily lives. Amanda holds a B.A. in Religion from Sewanee, The University of the South and a Master's Degree from Boston University in Public Health, with dual concentrations in Health Law, Bioethics, Human Rights and Health Services.  She's also a certified yoga instructor (200 Hour RYT) and Reconnective Healing practitioner.See omnystudio.com/listener for privacy information.

Join us in the third episode of our engaging retrospective series as we explore pivotal insights into womxn's health, healthcare, and data. Bethany Corbin leads a compelling discussion, shedding light on crucial considerations for womxn. Tune in now for this thought-provoking conversation. Female reproductive rights in the post-Dobbs era and how you should be mindful of the menstrual tracking apps you are usingThe unjust disparities in navigating the reproductive health landscape for men and womxn Powerful methods for protecting womxn's rights to data privacy and reproductive healthRisks in period and pregnancy tracking apps and what you can do to prevent your data from being monetized  Womxn's health tracking apps that are the most data-hungry and those that have the best data privacy protection Resources mentioned in this episodeSurfshark About Bethany CorbinAs a healthcare innovation and femtech attorney, Bethany is on a mission to help thought-leading companies revolutionize the global womxn's health sector. She founded FemInnovation, which helps transform and disrupt “standard” care delivery for womxn's health through specially tailored legal and educational programs, thought leadership, and advocacy. Bethany is a recognized leader and was named among the Top 200 Trailblazing Leaders in Women's Health and Femtech.Bethany's strategic insights have been featured in top news outlets. She has testified about the importance of data privacy for reproductive health before the Maryland Cybersecurity Council's Ad Hoc Committee on Consumer Privacy. She is an Advisory Board Member for Kisaco Research's Women's Health Innovation conference series. She is also a recipient of the 2023 Champion in Healthcare Award by the Global Health Conferences.Connect with Bethany Website: Femtech Lawyer Podcast: Legally FemtechLinkedIn: Bethany Corbin | FemInnovation Support the show!Want to learn more about us? Visit our website at www.periodtopause.com or send an email to amanda@periodtopause.comFollow us on Instagram: @periodtopauseFollow our Facebook Page: Period to Pause